Peripal AG, a medical technology company focused on innovations in peritoneal dialysis at home, today announced changes in its leadership.
Dr. Sandra Neumann, current CEO and Co-founder, is elected as the chairwoman of the Board. “Building Peripal AG from a small startup and an R&D team towards a commercially driven growth company has been the most satisfying work of my career”, says Sandra. “In my future board role, I have the opportunity to focus on strategic work and business development as well as to further pursue Peripal’s vision.” Sandra will succeed Reto Koch who will remain a member of the Board. Reto acted as the Chairman of the Board since the beginning and successfully led the Board over the last years.
Read more below